Squarepoint Ops LLC Astrazeneca PLC Call Options Transaction History

Squarepoint Ops LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $16.6 Million - $19 Million	216,600 Added 121.82%	394,400 $30.7 Million
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $11.5 Million - $13.9 Million	-171,700 Reduced 49.13%	177,800 $13.9 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $7.2 Million - $8.2 Million	117,900 Added 50.91%	349,500 $23.7 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $7.19 Million - $8.05 Million	116,200 Added 100.69%	231,600 $15.6 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $27.8 Million - $30.2 Million	-397,800 Reduced 77.51%	115,400 $8.26 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $11.7 Million - $13.3 Million	185,700 Added 56.7%	513,200 $35.6 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $14.8 Million - $19.2 Million	272,800 Added 498.72%	327,500 $22.2 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $2.08 Million - $5.33 Million	39,300 Added 255.19%	54,700 $3 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $912,604 - $1.1 Million	15,400 New	15,400 $1.02 Million

1,359

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.